Skip to content

Clinical trials

Thyroid Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Country / region: China Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20102
20112
20121
20142
20153
20166
201710
201810
20194
20209
20214
202216
202311
202419
202518
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status42
Recruiting41
Completed35
Not yet recruiting7
Active, not recruiting4
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fujian Medical University16
Fudan University14
Peking Union Medical College Hospital6
Second Affiliated Hospital, Zhejiang University, School of Medicine5
Bo Wang,MD4
Shandong Provincial Hospital4
Chinese PLA General Hospital3
Shanghai 6th People's Hospital3
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University3
The First Affiliated Hospital of Xiamen University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms131
Lung Neoplasms10
Neoplasms10
Thyroid Cancer, Papillary9
Colorectal Neoplasms7
Thyroid Diseases7
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung6
Pancreatic Neoplasms6
Thyroid Nodule6

Trials

Showing 1 to 25 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.